Latest Innovation News

Aurora Labs has signed a landmark MOU with European defence giant MBDA to explore integrating its 3D-printed turbojet engines into advanced missile systems, marking a significant step into international defence markets.

Group One Capital has finalized a structured funding facility for the 107-unit Ahlie residential development in Canberra, setting the stage for milestone-driven revenue of up to $6 million over the project lifecycle.

Elevate Uranium has successfully assembled its U-pgrade™ Demonstration/Pilot Plant in Namibia, with steady state operations expected to start in January 2026. This milestone aims to validate a proprietary beneficiation process that could transform uranium processing economics.

Korab Resources reports significant gold and base metals exploration progress at its Rum Jungle Project, alongside innovative mining method evaluations and ongoing legal challenges to key lease renewals.

ABx Group has secured a new five-year exploration licence in northern Tasmania, expanding its rare earths tenure between key deposits and advancing its high-value rare earth product development.

Metallium Ltd has secured a strategic partnership with ElementUSA to deploy its Flash Joule Heating technology for recovering gallium and scandium from red mud in Louisiana, backed by US$10.1 million in non-dilutive funding. This collaboration positions Metallium at the forefront of the US critical minerals supply chain expansion.

4DMedical has locked in $30.2 million through an underwriting agreement ensuring full exercise of its listed options, lifting its cash reserves to $63.7 million and setting the stage for a pivotal year in commercialising its CT – VQ™ technology.

Artrya Limited has begun generating fee-per-scan revenues from its Salix Coronary Plaque module at Tanner Health in the U.S., marking a key commercial milestone for the AI-powered cardiac imaging platform.

Acrux Limited has sold the US registration and distribution rights for its Prilocaine 2.5% and Lidocaine 2.5% cream for US$550,000, redirecting resources towards its growing Hormone Replacement Therapy portfolio.

Rhythm Biosciences has begun commercialising ColoSTAT®, its blood-based colorectal cancer diagnostic test, following an updated ISO15189, 2022 accreditation. The test offers a new option for symptomatic patients where stool-based screening is unsuitable.

HITIQ has secured a prestigious grant from the Australian Sports Commission to enhance its PROTEQT™ brain health monitoring technology, positioning the company for wider adoption across elite and community sports.

Nickel Industries has secured approval to increase its 2025 nickel ore sales quota by 1.5 million wet metric tonnes, enabling immediate sales resumption. This milestone is underpinned by a groundbreaking environmental permit that supports innovative, sustainable mining practices.